Krill Oil is an oil that is derived from krill; it contains the same two fatty acids that Fish Oil contains (Eicosapentaenoic Acid, or EPA, and Docosahexaenoic Acid, DHA). However, a large portion of the EPA and DHA in krill is in the form of a phospholipid, with a phosphate group on the end of the fatty acid. This results in higher bioavailability (rate of absorption) of krill oil, and thus the same effects of Fish Oil can be seen with Krill Oil but at a lower dose.
Follow this Page for updates
Supplementation of Krill oil tends to be in the range of 1-3g daily (overall oil weight), which has been used in the clinical trails of krill oil supplementation.
If supplementing in accordance with the omega-3 content, the omega-3 content that is supplemented from krill oil should be equal to approximately 2/3rds that used with basic Fish Oil supplementation to account for the increased absorption. If one were to normally supplement 1000mg EPA plus DHA, then 660mg of EPA and DHA from krill oil would be equivalent.
The Human Effect Matrix looks at human studies (excluding animal/petri-dish studies) to tell you what effect Krill Oil has in your body, and how strong these effects are.
|Grade||Level of Evidence|
|A||Robust research conducted with repeated double blind clinical trials|
|B||Multiple studies where at least two are double-blind and placebo controlled|
|C||Single double blind study or multiple cohort studies|
|D||Uncontrolled or observational studies only|
|Level of Evidence ||Effect||Change||Magnitude of Effect Size ||Scientific Consensus||Comments|
A decrease in C-Reactive protein has only been noted in rheumatoid arthritis (none in obese but healthy persons) but reached 30% within 30 days of 500mg krill oil, a very... show
A decrease in triglycerides has been noted with krill oil
A decrease in total cholesterol has been noted with krill oil, to a fairly normal degree (reduction is lessened from the remarkable increase in HDL)
Although one study suggest no such increase (healthy persons), the increase seen in hyperlipidemics exceeded 50% and was remarkable; requires replication
A decrease in LDL-C has been noted with krill oil, which appears to be to quite a significant degree
No significant influence on weight over time
No significant influence on blood glucose levels
No significant influence on fasting insulin levels
On obese subjects, this endocannabinoid has been found to be reduced somewhat
|C||Symptoms of Rheumatoid Arthritis|
500mg Krill oil reduced symptoms of osteoarthritis up to 30%, which is a pretty significant effect size that requires future research to investigate.
|C||Functionality in Elderly or Injured|
The increase in functionality appears to be secondary to reductions in symptoms of rheumatoid arthritis
|C||Symptoms of PMS|
PMS and its symptoms (breast tenderness, stress, and irritability mostly) have been reduced with krill oil supplementation
Secondary to reducing symptoms of PMS, a reduction in breast tenderness has been reported
Irritability as a side-effect of PMS has been reduced with supplemental krill oil
Stress as a side-effect of PMS has been reduced with supplemental krill oil
Despite containing PUFAs, no significant changes in lipid peroxidation
A decrease in Apolipoprotein A has been noted with krill oil supplementation
No significant influence on Apolipoprotein B noted
Euphausiacea (commonly called 'Krill', which refers to the entire Euphausiacea family but can come from the atlantic or pacific in which the species are referred to as superba and pacifica, respectively) is a family of small sea creature (crustacean) which confers some dietary eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA), the two fatty acids that are the active components of Fish Oil and can increase plasma levels of EPA and DHA. Krill tends to have similar DHA content to oily fish with a slightly higher EPA content (per weight basis). The krill itself does have a respectable and bioavailable protein content (11.9-15.4% total animal weight; lipids consist of 0.5-3.6% total weight and 12-50% dry weight), but the oil itself is not a Protein Supplement due to processing most amino acids out of the oil; nutritionally, krill is similar to shrimp.
What tends to make krill unique from fish oil is the collection of fatty acids in the form of phospholipids rather than triglycerides, which is a phenomena that separates crustacean animals from fish in general; while crustaceans have been reported to have up to 65% of total fatty acids bound as phospholipids krill has been quantified in the 28-58% range.
Krill oil fatty acids tend to be diacylglycerides (two fatty acids bound to a glycerol molecule) rather than triglycerides, and due to binding to a phosphatidic acid group at the final binding site the structure is a phospholipid in nature.
Fish oil supplementation tends to be triglycerides while Lovaza (brand name) are ethyl esters.
Structurally, the fatty acids are bound in phospholipid form. While they confer the same benefits as the fatty acids, there are some differences in the absorption kinetics and the phospholipid itself may also be bioactive
The fatty acid breakdown of krill oil appears to be 26.1-30.7% saturated fatty acids, 24.2-25.9% monounsaturated fatty acids, and 34.1-48.5% omega-3 polyunsaturated fatty acids; the final 2.5% consists of omega-6 fatty acids. The individual fatty acid breakdown of krill oil (not considering the structural form) is:
Krill oil is high in the two fatty acids commonly said to underlie the benefits of fish oil, although on a per weight basis they appear to be a tad lower than fish oil due to a higher percentage of saturated fats in krill oil; krill oil is low in omega-6 fatty acids and has a respectable monounsaturated fat content which is fairly balanced with the omega-3 and saturated content
Of these fatty acids, between 28-58% are bound as phospholipids and appear to be mostly Phosphatidylcholine (48 to 80% of various combinations), with some phosphatidylethanolamine (1.5-8%) and phosphatidylglycerol (1%); some studies reported a high (21-24%) unidentifiable component which is possibly Phosphatidylserine but not confirmed to be so. The overall phosphatidylcholine content has been calculated once to be 34+/-5g per 100g oil. Phosphatidylinositol appears to be negligible.
Approximately a bit more than half of the fatty acids are bound in the form of phospholipids, with phosphatidylcholine being the most prominent one. Other phospholipids and variants of mono/diacylglycerol molecules are also present, but likely to play minor roles
Other components of krill oil that may also confer bioactivity include:
There appear to be a phenolic and cholesterol content in krill oil as well, with the Astaxanthin content of the oil likely being too low to matter as a supplement itself (ie. the benefits on the astaxanthin page may not apply to orally ingested krill oil)
Fluoride contamination is thought to be an issue with krill oil supplementation as the exoskeletal of krill is very high in naturally occurring fluoride (350mg/100g) and while the tissue is low, upon death fluoride may migrate from the exoskeleton into the meat (up to 9mg/100g has been reported) if the shell is not immediately removed. This fluoride is well absorbed by mammals, but isn't thought to be a concern with immediate removal of the exoskeleton as over 99% of fluoride is localized there. It is uncertain how or if this is a concern to krill oil supplementation.
There is likely to be low risk of mercury in krill oil sourced EPA and DHA, mainly due to positive correlations between fish size and predatory status with mercury content (putting fish such as shark, albacore tuna, and swordfish high in mercury concentrations with prawn, herring, and small fish lower); however, this does not appear to be directly assessed.
There is a logical basis for worry about fluoride contamination, but the exact level of concern towards krill oil supplements is not known. This concern can be heavily alleviated by proper processing and handling practises of krill
Freezing of krill appears to reduce the phospholipid content by up to 15% after 30 days of storage following freezing with about half of the phospholipids being destroyed after 7 months.
Due to the astaxanthin content, the fatty acids in krill oil appear to be more resistant to oxidation as astaxanthin appears to be destroyed sacrificially.
When testing the bioavailability of various forms of fish oils, Krill oil appears to be the most well absorbed. In a study with 1680mg oils, Krill oil elicited an AUC of 80.03+/-34.71% compared to Fish Oil triglycerides of 59.78+/-36.75% and fish oil ethyl esters at 47.53+/-38.42% (33% better absorbed than fish oil, 68% better absorbed than ethyl esters).
Krill oil appears to be better absorbed than fish oil and fish oil ethyl esters
Oral intake of krill oil (500mg krill oil conferring 90.5mg combined EPA/DHA) has been confirmed to increase plasma DHA and EPA, as well as the intermediate (docosapentaenoic acid) and arachidonic acid; similar to fish oil.
Although not directly linked to Krill oil, it appears that supplemental DHA (3% of lipids) in the form of phospholipids (37.2% Phosphatidylcholine and 36.6% lyso-PC) appears to have more antioxidative effects in the brains of rats injected with the toxin streptozotocin relative to DHA in triglyceride form (Fish Oil supplementation).
May be more neuroprotective than fish oil supplementation on a gram per gram basis as assessed by its antioxidant effects
2-arachidonoylglycerol is an endocannabinoid that is increased in obese subjects (alongside anandamide) and can be induced during high fat animal feeding yet appears to be reduced in obese subjects following consumption of 2g of krill oil (216mg EPA and 90mg DHA) for 4 weeks while anandamide is unaffected; this reduction is also noted in rats. These endocannabinoid molecules are derived from arachidonic acid, and the lowering of plasma arachidonic acid with Fish Oil fatty acids (EPA and DHA) is thought to underlie the observed effects.
Krill oil is thought to confer memory promoting properties due to consisting of both Fish Oil fatty acids and Phosphatidylcholine, both of which have individually been linked to a betterment of memory and learning; some authors suspect the Astaxanthin content also plays a role due to its individual anxiolytic and cognitive enhancing properties.
Phospholipids from krill have been noted to increased performance in a radial maze test in adult rats at 301-420mg/kg EPA+DHA associated with neurogenesis in the dentate gyrus of the hippocampus. This study noted that 100mg/kg EPA+DHA was ineffective. Elsewhere, adult rats of both sexes given krill oil at 1.25% of the diet for six weeks (200mg per rat, or 1,000-1,333mg/kg) noted a cognitive enhancing effect (as assessed by lever discrimination) with mixed antidepressive effects that did not outperform Imipramine.
Krill oil is linked to an improvement in memory in adult rats without overt cognitive degeneration, but requires quite a high oral dose for this to occur with the human equivalence exceeding 160mg/kg bodyweight
Menstrual cramping appears to be associated with a release of arachidonic acid following the menstration-induced reduction in progesterone which triggers a flux of prostaglandins and leukotrienes in the uterus; this increase causes localized production of COX-mediated metabolites of arachidonic acid (prostaglandin F2 and E2) which cause vasoconstriction and myometrial contractions that underlie cramping. It is though that the Fish Oil fatty acids of EPA and DHA may reduce the physical symptoms of PMS via competing with arachidonic acid in producing less inflammatory prostaglandins.
One study has assessed the effects of 2g Krill oil daily over 90 days in women with diagnosed PMS, and found that supplementation caused a time-dependent improvement in all measured symptoms (breast tenderness, bloating, stress, irritability, depression, weight gain, etc.) that outperformed the control of fish oil despite having similar EPA and DHA content. This study noted that both fish oil and krill oil were effective on physical symptoms of bloating, cramping, and weight gain although only krill oil had neural benefit.
Fish oil fatty acids in general are thought to alleviate some symptoms of PMS (mostly related to cramping), and while krill oil has once been noted to be effective in this regard it has also reduced neural symptoms of PMS such as irritability and outperformed fish oil
Supplemental krill oil has been confirmed to increase the omega-3 content of cardiac tissue in rats and pretreatment of krill oil prior to myocardial infarction can reduce the subsequent cardiac hypertrophy; rehabilitative supplementation does not appear as effective.
It has been noted that krill oil supplementation (3,000mg) has roughly comparable effects on lipoproteins and triglycerides as fish oil (1,600mg), although this study noted null results with both interventions in otherwise healthy persons. Similarly, supplementation of 2,000mg krill oil daily for 21 days during a 'Daniel Fast' (vegan, plant based diet) failed to modify the diet-induced reduction in HDL-C in otherwise healthy persons.
In hyperlipidemic persons, krill oil supplementation at 1,000-1,500mg daily for 90 days has been implicated in increasing HDL-C (42.76-43.92%) and reducing LDL-C (32.03-35.70%), total cholesterol (13.71-13.44%), and triglycerides (11.03-11.89%) with all benefits being slightly greater with 2-3g daily; the improvement in HDL-C reached 59.64% and the reduction in LDL-C reached 39.15% at 3g daily, and all treatments greatly outperformed the reference drug of Fish Oil (3g daily).
In a rat model of rheumatoid arthritis (collagen injections; 0.44% of the diet as EPA+DHA from krill oil said to correspond to 1.8g in humans) was able to reduce paw thickness and arthritic score to a level greater than fish oil at the same oral EPA+DHA dose. No measured cytokines (IL-1α, IL-1β, IL-7, IL-10, IL-12p70, IL-13, IL-15, IL-17 and TGF-β) appeared to be altered.
When tested in humans, supplementation of krill oil at 300mg daily for 30 days was able to significantly improve WOMAC ratings in the range of 20.3-28.9% (depending on subscale) in persons with rheumatoid arthritis.
May confer benefit to rheumatoid arthritis based on the animal research, which is a mechanism shared with fish oil. It appears to be better than fish oil, but this may simply be due to better absorption (and the difference becoming insignificant with higher fish oil intake relative to krill oil)
Feeding rats a high fat diet paired with or without 2.5% krill oil is able to attenuate, but not abolish, the increases in glucose while effectively preventing the increase in insulin from occurring which has been noted elsewhere in rats on a high fat fed diet with a bit more efficacy in oil with a higher polyunsaturated fat (PUFA) and phospholipid content.
Krill oil has been noted to have differential effects relative to Fish Oil in the liver, where after supplementation of the diet with either krill oil (1.5%) or fish oil (1.1%) with similar EPA+DHA concentrations (0.29-0.31%) noted that Krill oil was able to activate 4,892 analyzed genes (20,118 assessed overall) whereas fish oil activated 192. Both treatments seem to suppress hepatic glucose production, but only krill oil suppressed lipogenic genes (SREBF1, MLXIPL) while the increase in activity of the cholesterol biosynthesis pathway was noted to be a decrease with krill oil. Elsewhere, krill oil has been noted to increase β-oxidation of fatty acids whereas fish oil is ineffective.
There is evidence for different effects between Krill oil and fish oil on the liver that extend beyond merely being a better absorbed form of the fatty acids.
When a high fat diet is paired with 2.5% krill oil in rats, the increase in overall weight gain and liver weight gain is abolished (1.25% merely attenuates) which is thought to be secondary to a reduction (55%) of citrate influx into the mitochondria and subsequent fatty acid synthesis (related to less Vmax of the transporter) and increase in hepatic fat oxidation (3.4-fold more than high fat control, 2.1-fold more than normal control). This reduced rate of the tricarboxylate transporter has been noted elsewhere, which resulted in a decrease in lipogenesis in the liver.
In animals, krill oil has been demonstrated to reduce liver fat accumulation during overfeeding via reducing the rate of a transporter involved in lipogenesis. It appears to do so to a degree greater than fish oil even when fatty acids (EPA and DHA) are controlled
5% krill oil in the diet of rats given chemical-induced ulcerative colitis (via dextran sulfate sodium) was able to confer protective effects which were thought to be secondary to reducing inflammatory events.
May be of use against ulcerative colitis; has not been directly compared against fish oil (to assess comparative potency)
(Common misspellings for Krill Oil include kill, kril, crill, cril, cill)
(Common phrases used by users for this page include science on krill oil, krill oil supplements, krill oil liver enzymes, krill oil bioavailability, krill oil 3000mg daily dosage, how many mg of krill oil for daily supplement)